{ }
Very Negative
Negative
Neutral
Positive
Very Positive
2025-04-032025-04-031111100
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-04-032025-04-031111100
Download SVG
Download PNG
Download CSV

Roche's new strategy focuses on promising drugs and streamlined research efforts

Roche, under CEO Thomas Schinecker, is streamlining its operations by focusing on five key therapeutic areas: neurology, oncology, eye diseases, immunology, and cardiovascular/metabolic diseases. The company is prioritizing promising drugs like CT-388, an injection aimed at significant weight loss, while addressing internal inefficiencies and aiming for faster clinical trials. Despite setbacks, Roche is determined to enhance its drug pipeline and maintain competitive growth in the pharmaceutical market.

spi index declines as top shares fluctuate amid market volatility

The SPI index fell by 0.24% to 16,092.74 points, reflecting a 1.04% decline since the start of the week. Year-to-date, the index has risen by 10.45%, with a high of 16,557.98 points and a low of 14,455.60 points recorded this year. Top performers include Schlatter Industries and EFG International, while HOCHDORF and DocMorris faced significant losses.
09:00 02.10.2024

weak trading in zurich spi index declines amid mixed stock performance

Weak trading in Zurich saw the SPI index drop 0.20% to 16,290.51 points at the start of Monday, with a market capitalization of €2.200 trillion. The index has risen 11.81% since the beginning of 2024, with a high of 16,557.98 points and a low of 14,455.60 points this year. Curatis led gains with a 6.86% increase, while Meyer Burger Technology faced the largest decline at -10.98%.
09:00 30.09.2024

nestlé stock market decline poses risks for pension fund investors

Nestlé's stock market struggles are affecting pension fund investors, as the company is a key component in many pillar 3a products, including UBS's Vitainvest and ZKB's Frankly range. These funds, heavily influenced by the Swiss Market Index, face challenges due to the uncertain outlook for major index players like Nestlé, Novartis, and Roche. Björn Eberhardt from Luzerner Kantonalbank warns that investors in index products may not see significant price gains under these conditions.
09:00 28.09.2024

strong performance in zurich as spi index rises and trading volumes increase

The SPI index in Zurich rose 0.33% to 15,946.16 points, with a market capitalization of 2.122 trillion euros. Notable gainers included Perrot Duval SA (+71.25%) and Relief Therapeutics (+9.87%), while Curatis (-21.03%) and Calida (-13.12%) were among the biggest losers. Nestlé led in trading volume with over 1.5 million shares exchanged.
09:00 23.09.2024
Trending
Subcategory
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.